Karyotyping banner

Non-Invasive Prenatal Testing (NIPT)

Advanced. Safe. Reassuring.

Book a Test Consult our Experts

Home / Services / Non-Invasive Prenatal Testing (NIPT)

What is Non-Invasive Prenatal
Testing (NIPT)?

Non-Invasive Prenatal Testing (NIPT) represents a revolutionary advancement in prenatal screening that analyzes cell-free DNA (cfDNA) circulating in a pregnant woman's bloodstream. This cutting-edge technology examines genetic material naturally released from the placenta into the maternal circulation, allowing for highly accurate assessment of chromosomal conditions without any risk to the pregnancy.

NIPT provides exceptional sensitivity and specificity for detecting common chromosomal aneuploidies, particularly those involving chromosomes 21, 18, 13, X and Y.

Learn more
what is FISH
Karyotyping recommended

Recommendation

When is NIPT Recommended?

  • All Pregnancies: As a primary screening option for any expectant mother seeking information.
  • Advanced Maternal Age: For women 35 years or older at delivery.
  • Abnormal Serum Screening: Following unexpected results from traditional blood screening tests.
  • Concerning Ultrasound Findings: When imaging suggests increased risk for chromosomal conditions.
  • Previous Pregnancy: With a history of chromosomal abnormality.
  • Family History: When chromosomal conditions run in the family.
  • Twin Pregnancies: For safe screening of multiple gestations.
  • IVF Pregnancies: Following assisted reproductive technologies.

NIPT offers peace of mind with a simple blood draw - no needles near your baby, no risk of miscarriage and exceptional accuracy as early as 10 weeks into pregnancy.

Our Advantage

Our NIPT Advantage

At Suraksha Genomics, our NIPT service delivers industry-leading accuracy with next-generation sequencing technology:

Key Features

  • Exceptional Accuracy : >99% detection rate for trisomy 21 (Down syndrome).
  • Early Detection : Available from 10 weeks of pregnancy onward.
  • Completely Non-Invasive : Simple maternal blood draw with zero risk to the fetus.
  • Rapid Results : Reports available within few days.
  • Next-Generation Sequencing : Utilizing advanced Next-Generation Sequencing Technology.
  • Low Failure Rate : <1% non-reportable results due to our optimized laboratory protocols.

What NIPT Screens For

Our comprehensive NIPT service screens for:

  • Trisomy 21 : Down Syndrome
  • Trisomy 18 : Edwards Syndrome
  • Trisomy 13 : Patau Syndrome
  • Sex Chromosome Aneuploidies : Including Turner syndrome (45,X), Klinefelter syndrome (47,XXY), Triple X syndrome (47,XXX), and 47,XYY syndrome

Testing Process

The NIPT Process

Sample Collection

Simple Blood Collection

A standard 10ml blood sample drawn from the mother's arm.

Sample Collection

Laboratory Processing

Cell-free DNA extraction and analysis using next-generation sequencing in our CAP-accredited facility.

Sample Collection

Bioinformatic Analysis

Advanced algorithms assess chromosomal representation and calculate risk scores.

Sample Collection

Expert Interpretation

Comprehensive review by our molecular genetics specialists.

Sample Collection

Clear Reporting

Results delivered to your healthcare provider within 5-7 working days.

Sample Collection

Post-Test Counseling

Expert consultation to explain findings and discuss next steps if needed.

Why Suraksha Genomics?

Why Choose Suraksha Genomics for NIPT?

  • Next-Generation Sequencing Platform : Utilizing the latest whole-genome sequencing technology for optimal sensitivity and specificit.
  • Exceptional Laboratory Expertise : Testing performed by specialists with extensive experience in prenatal genomics.
  • Comprehensive Genetic Services : Seamless access to confirmatory testing if needed (QF-PCR, FISH, karyotyping).
  • Dedicated Genetic Counseling : Professional guidance before and after testing.
  • Stringent Quality Controls : Rigorous internal and external quality assurance measures.
  • Trusted by Specialists : Preferred NIPT provider for leading obstetricians and maternal-fetal medicine specialists across Eastern India.

your Result

Understanding NIPT Results

Low Risk

Indicates very low probability of the tested chromosomal conditions.

High Risk

Suggests increased likelihood of a specific chromosomal condition.

No Result

In rare cases (<1%), insufficient fetal DNA may require a repeat sample.

Important Note: While NIPT is highly accurate (>99% for Down syndrome), it remains a screening test. High-risk results should always be confirmed through diagnostic testing such as amniocentesis or CVS before making any pregnancy decisions.

FAQs

Frequently Asked Questions

What is NIPT?

NIPT is a safe and highly accurate blood screening test for pregnant women. It analyzes small fragments of your baby's DNA (cell-free DNA) that circulate in your bloodstream to assess the likelihood of certain chromosomal conditions.

Who should consider NIPT?

NIPT is recommended and can be offered to all pregnant women, regardless of age or risk level, as early as 10 weeks of pregnancy.

How is NIPT performed?

It involves a simple blood draw from the mother's arm. There is no risk to the baby.

What if my NIPT result is high-risk?

A high-risk NIPT result indicates an increased chance of a chromosomal condition, but it is not a diagnosis. Your doctor or a genetic counselor will discuss the result with you and may recommend confirmatory diagnostic testing like amniocentesis or CVS, followed by tests like Karyotyping or Microarray.

Have Questions?

We understand that prenatal testing involves important choices. Our team of specialists is available to address your concerns, explain procedures, and provide the support you need throughout your pregnancy journey.

Contact our team today. Experience the reassurance that comes from state-of-the-art non-invasive prenatal screening at Eastern India's premier genetics laboratory.

Consult our experts